Exciting - how many more of these value accretive announcements are in the pipeline
- Forums
- ASX - By Stock
- PNV
- Ann: First Patient enrolled - SynPath Diabetic Foot Ulcer Trial
Ann: First Patient enrolled - SynPath Diabetic Foot Ulcer Trial, page-4
-
- There are more pages in this discussion • 47 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PNV (ASX) to my watchlist
|
|||||
Last
$2.65 |
Change
0.065(2.52%) |
Mkt cap ! $1.780B |
Open | High | Low | Value | Volume |
$2.60 | $2.65 | $2.56 | $2.183M | 834.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
28 | 16807 | $2.64 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.65 | 33228 | 24 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
27 | 18209 | 2.640 |
15 | 39703 | 2.630 |
15 | 36386 | 2.620 |
16 | 82583 | 2.610 |
13 | 24985 | 2.600 |
Price($) | Vol. | No. |
---|---|---|
2.650 | 28847 | 17 |
2.660 | 36217 | 17 |
2.670 | 35881 | 12 |
2.680 | 79363 | 14 |
2.690 | 218515 | 9 |
Last trade - 12.52pm 31/07/2024 (20 minute delay) ? |
Featured News
PNV (ASX) Chart |
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, CEO
Anthony Noble
CEO
SPONSORED BY The Market Online